MétaCan
Menu
Back to cohort
Record W4400126202 · doi:10.1093/bjd/ljae090.360

H12 A history of evidence-based medicine and dermatology as an early adopter

2024· article· en· W4400126202 on OpenAlexaboutno aff
Hannah Binns

Bibliographic record

VenueBritish Journal of Dermatology · 2024
Typearticle
Languageen
FieldMedicine
TopicMedicine and Dermatology Studies History
Canadian institutionsnot available
Fundersnot available
KeywordsEarly adopterDermatologyMedicineBusinessMarketing

Abstract

fetched live from OpenAlex

Abstract In 1992, a search for evidence-based medicine (EBM) would have only yielded two articles. Now, searching this term in PubMed generates over 276 000 results. But how did the ‘era of evidence-based medicine’ begin and what were its foundations? The concept of using evidence to guide medical practice is thought to date back to Ancient Greece. However, it was not until the 20th century that it started to take hold in modern medicine. Social principles calling for effective healthcare for the masses were a driving force, with British clinical epidemiologist Archie Cochrane (1909–1988) being the first advocate of this practice. Predating Archie Cochrane’s work, the early 20th century’s advancement in statistics and development of the meta-analysis would form the building blocks for modern-day EBM. British statistician Karl Pearson was the first to propose the concept of combining results of individual studies to minimize random error. Later in the 1920s fellow Briton, Ronald Fisher laid the foundation for the systematic approach by developing the statistical method of meta-analysis, first called ‘Fisher’s combined probability test’. In 1976 American statistician Gene Glass coined the term ‘meta-analysis’. By 1989 meta-analysis was changing clinical practice. Sir Ian Chalmers demonstrated that a short course of corticosteroids could drastically reduce complications following delivery of preterm infants. His work, and that of others, highlighted that lives could be saved through the evidence-based approach of performing up-to-date systematic reviews of randomized clinical trials. Meanwhile, in Canada the EBM movement was starting. In 1981 a group led by David Sackett published the first of a series of articles on how to appraise medical literature, influencing the practice of a whole generation. The actual term EBM was announced by Sackett’s mentee Gordon Guyatt in 1992. The levels of evidence that we use today can be attributed to Sackett and his book Evidence-Based Medicine: How to Practice and Teach EBM, which gave clinicians the tools to adopt EBM into everyday practice. Dermatology was an early adopter of EBM. The Cochrane Skin Group (CSG) was founded by Hywel Williams in 1997, with the clear aim of disseminating evidence-based guidelines to prevent, diagnose and treat dermatological disease. The first CSG review was published in 1999, and to date there are 130 active systematic review titles. The work of the CSG elicits tangible effects on international health policy, contributing to national and international guidelines. The work of the CSG is bolstered by the UK Dermatology Clinical Trials Network at the Centre of Evidence Based Dermatology, a group that aims to explore research gaps identified by the CSG reviews.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.032
metaresearch head score (Gemma)0.061
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesScience and technology studies
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.997
Threshold uncertainty score0.170

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0320.061
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0060.004
Science and technology studies0.0030.026
Scholarly communication0.0110.018
Open science0.0020.006
Research integrity0.0140.030
Insufficient payload (model declined to judge)0.0090.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.086
GPT teacher head0.323
Teacher spread0.236 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueBritish Journal of DermatologySame topicMedicine and Dermatology Studies HistoryFrench-language works237,207